Trulieve Acquires Harvest Health’s Cannabis Arm For Record US$2.1 bn

Summary

  • Florida-based marijuana company Trulieve (TCNNF) has acquired Harvest Health’s cannabis arm for a record US$2.1 billion in the biggest deal for the US cannabis industry to date.
  • It will now have a presence in 11 states from its current six, with access to 22 cultivation sites.
  • Harvest Health’s eye-popping deal has drawn interest from investors. The company had begun selling cannabis this year.

Florida-based marijuana company Trulieve (TCNNF) has acquired Arizona-headquartered Harvest Health’s cannabis arm for a record US$2.1 billion earlier this week. It is the biggest deal in the US cannabis business to date. Arizona has recently legalized cannabis.

Trulieve will now have footprints in 11 states from its current six states, with access to 22 cultivation sites and processing units. The sites have a total area of over 3.1 million square feet and 126 dispensaries. The facilities will cater to both medicinal and recreational markets. 

The deal shows the extent to which companies are ready to pay to get hold of their market. The federal government now allows the interstate marijuana trade. Harvest Health’s eye-popping deal has drawn interest from investors. The company had begun selling cannabis this year.


Also Read:
Alibaba’s revenues up 64% YoY, Adds 1 Billion Active Customers


Trulieve CEO Kim Rivers said the deal will help expand its operation in multiple US states since Harvest Health already has an extensive production and marketing network. Trulieve has a 50% market share in Florida and the deal will help it become a leader in Arizona and Pennsylvania.

Harvest Health (HRVSF) was valued at US$850 million after its merger with Chicago-based Verano Holdings last year.

Pic Credit: Pixabay.


Also Read:
What’s Next for Xiaomi After US Ban Revoked?

US Cannabis Industry

The deal proves why the US is an important cannabis market. Policymakers should further reform the marijuana law for the benefit of this growing industry, experts say. The legal US cannabis market generated US$18 billion in 2020, and it is expected to generate US$27.7 billion in 2021. It also created 3,21,000 jobs. Despite challenges and without federal backing, it has managed to come thus far, and which is why the government should support the industry, experts say.


Also Read: Renewables Get A Jumpstart After Biden’s US$2.8bn Wind Project

 

The cannabis investors hope the Biden administration would make further reforms for the industry to take root. Cannabis is a Schedule I drug at the federal level, which kept the companies out of the purview of the federally insured banking system.

They expect the Senate to pass the Secure and Fair Enforcement (SAFE) Banking Act 2021. The act is expected to pave the way for the cannabis industry to access financial services. It will bar regulators from terminating or limiting the share or deposit of financial institutions for doing business with cannabis companies.


Also Read:
Tesla Eyes Entry Into Multimillion-Dollar US Renewable Market


Disclaimer
The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.